investig
preval
human
bocaviru
hbov
human
coronavirus
hcov
human
polyomavirus
hpyv
among
patient
sever
acut
respiratori
ill
sari
south
africa
studi
includ
south
african
patient
randomli
select
agedefin
categori
hospitalis
patient
enrol
sari
surveil
multiplex
revers
transcript
realtim
polymeras
chain
reaction
assay
use
detect
hbov
washington
univers
hpyv
hpyvwu
karolinska
insitut
hpyv
hpyvki
respiratori
tract
specimen
collect
patient
sari
respiratori
specimen
patient
enrol
sari
surveil
also
routin
test
multiplex
revers
transcript
realtim
polymeras
chain
reaction
adenoviru
enteroviru
human
metapneumoviru
parainfluenza
viru
type
respiratori
syncyti
viru
rhinoviru
influenza
influenza
b
open
access
articl
term
creativ
common
attribut
licens
permit
use
distribut
reproduct
medium
provid
origin
work
properli
cite
result
human
bocaviru
hpyvwu
detect
respiratori
specimen
respect
virus
detect
specimen
rhinoviru
common
coinfect
viru
follow
adenoviru
respiratori
syncyti
viru
test
addit
virus
hbov
hcov
hpyv
decreas
number
specimen
initi
test
neg
conclus
inclus
laboratori
test
hbov
hpyvwu
differenti
test
algorithm
surveil
diagnost
suspect
case
respiratori
ill
unknown
caus
may
improv
understand
etiolog
sari
especi
countri
like
south
africa
high
number
immun
compromis
person
consent
patient
hiv
result
obtain
medic
record
avail
time
enrol
test
driedblood
spot
perform
nation
institut
communic
diseas
johannesburg
south
africa
human
immunodefici
viru
test
includ
polymeras
chain
reaction
pcr
children
age
month
enzymelink
immunosorb
assay
patient
age
month
nasopharyng
aspir
collect
children
age
year
combin
nasopharyng
oropharyng
swab
collect
person
age
year
specimen
place
viral
highveld
biolog
johannesburg
south
africa
univers
copan
murrieta
california
usa
transport
medium
store
within
hour
collect
specimen
transport
nation
institut
communic
diseas
johannesburg
south
africa
test
respiratori
specimen
store
sort
collect
date
subset
respiratori
specimen
randomli
select
agecategori
year
age
inclus
studi
total
specimen
collect
surveil
period
everi
eighth
specimen
systemat
select
inclus
studi
obtain
studi
sampl
specimen
test
use
multiplex
revers
transcript
realtim
pcr
rtqpcr
assay
follow
virus
hbov
hpyvwu
hpyvki
rtqpcr
assay
perform
use
paramet
cycl
condit
previous
describ
follow
modif
anchoredoligo
dt
primer
random
hexam
primer
use
revers
transcript
reaction
respiratori
specimen
sari
surveil
also
routin
test
multiplex
rtqpcr
assay
adv
enteroviru
hmpv
piv
type
rsv
rv
infa
infb
preval
hbov
hcov
hpyv
virus
compar
age
group
hivinfect
hivuninfect
individu
individu
without
nonhiv
underli
medic
condit
predominantli
asthma
heart
diseas
pregnanc
diabet
seizur
disord
malnutrit
use
chisquar
test
fisher
exact
test
version
statacorp
colleg
station
texa
usa
use
implement
analysi
among
patient
includ
studi
children
age
year
account
largest
proport
case
among
individu
avail
inform
hiv
preval
preval
nonhiv
underli
medic
condit
count
inform
avail
limit
number
individu
therefor
result
could
util
age
distribut
hiv
preval
case
includ
exclud
studi
statist
similar
tabl
among
hbov
hcov
hpyv
hbov
hpyvwu
frequent
detect
human
hpyvki
detect
specimen
detect
rate
hbov
hcov
hpyvwu
children
although
detect
hbov
specimen
test
case
hbov
mrna
viral
dna
load
assess
proport
case
activ
infect
describ
xu
et
al
similar
studi
conduct
south
africa
hospitalis
children
age
year
requir
medic
attent
hospit
test
sever
respiratori
virus
includ
test
studi
among
children
hbov
hpyvwu
detect
specimen
respect
studi
higher
preval
report
tabl
may
due
differ
case
definit
use
studi
find
similar
report
studi
conduct
gulf
region
children
year
age
latter
studi
report
detect
rate
virus
hbov
hpyvwu
global
hbov
hpyvwu
predominantli
observ
children
age
year
upper
lower
respiratori
tract
infect
also
observ
studi
recent
south
african
studi
found
among
children
age
year
hbov
hcov
detect
significantli
associ
sever
ill
human
polyomavirus
investig
latter
studi
therefor
inclus
laboratori
test
hbov
hpyvwu
differenti
test
algorithm
surveil
diagnost
suspect
case
respiratori
ill
unknown
caus
may
improv
understand
etiolog
sari
especi
countri
like
south
africa
high
number
immun
compromis
person
studi
limit
warrant
discuss
first
patient
sari
includ
studi
control
particip
group
evalu
associ
andor
fraction
hbov
hcov
hpyv
detect
may
contribut
sever
respiratori
ill
could
investig
second
sampl
size
small
seropreval
data
south
africa
lack
therefor
use
expect
preval
obtain
biggest
sampl
size
confid
interv
desir
absolut
precis
design
effect
plu
inflat
spoilagequ
sampl
annual
expect
sampl
studi
year
lastli
studi
durat
short
period
requir
assess
season
therefor
season
hbov
hcov
hpyv
determin
conclus
low
preval
hbov
hpyvwu
similar
higher
import
virus
commonli
test
hmpv
piv
type
infa
infb
includ
test
hbov
hcov
hpyv
virus
differenti
diag
